Literature DB >> 21277898

Function of CD27 in helper T cell differentiation.

Sten Libregts1, Ronald W van Olffen, Koenraad F van der Sluijs, Rene A W van Lier, Martijn A Nolte.   

Abstract

Differentiation of naïve CD4(+) T cells to functional effector T-helper (T(H)) cells is driven by both costimulatory molecules and cytokines. Although polarizing cytokines can induce the differentiation into a particular T(H)-subset, certain costimulatory molecules also seem to affect this polarization process. We have previously found that CD70-transgenic (CD70TG) mice develop large numbers of IFN-γ-producing CD4(+) T cells and we therefore questioned whether CD27 triggering provides an instructive signal for T(H)1 differentiation or rather supports T(H) cell formation in general. Although CD70TG mice on a T(H)1-prone C57Bl/6J background develop more T(H)1 cells, we found that this phenotype is lost when CD70TG mice are fully backcrossed on a T(H)2-prone Balb/c background, but is not replaced with more T(H)2 cells. Furthermore, CD70-overexpression is not sufficient to drive T(H)17 cell formation, nor does it affect the generation of FoxP3(+) regulatory T cells. Using an in vitro setting, we found that CD27-triggering does not provide instructive signals for a specific T(H) cell subset, but, depending on the cytokine milieu and genetic background, supports T(H)1 cell formation, while it inhibits the formation of T(H)17 but not T(H)2 cells. Induction of allergic airway inflammation in CD70TG Balb/c mice further illustrates that CD27 plays a supportive role in T(H)1 differentiation in vivo, without modulating the classical T(H)2 response. This supportive role of CD27 in T(H) cell polarization could not be attributed to a specific change of transcription factor expression levels. In summary, this study indicates that CD27 signalling does influence T(H) cell differentiation, but that it is highly dependent on the conditions and genetic background.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277898     DOI: 10.1016/j.imlet.2011.01.008

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  9 in total

Review 1.  Stimulating CD27 to quantitatively and qualitatively shape adaptive immunity to cancer.

Authors:  Timothy Nj Bullock
Journal:  Curr Opin Immunol       Date:  2017-03-17       Impact factor: 7.486

Review 2.  Dendritic cells as gatekeepers of tolerance.

Authors:  Ari Waisman; Dominika Lukas; Björn E Clausen; Nir Yogev
Journal:  Semin Immunopathol       Date:  2016-07-25       Impact factor: 9.623

3.  CD27 Promotes CD4+ Effector T Cell Survival in Response to Tissue Self-Antigen.

Authors:  Kelly A Remedios; Lauren Meyer; Bahar Zirak; Mariela L Pauli; Hong-An Truong; Devi Boda; Michael D Rosenblum
Journal:  J Immunol       Date:  2019-06-17       Impact factor: 5.422

4.  Co-expression of a PD-L1-specific chimeric switch receptor augments the efficacy and persistence of CAR T cells via the CD70-CD27 axis.

Authors:  Le Qin; Yuanbin Cui; Tingjie Yuan; Dongmei Chen; Ruocong Zhao; Shanglin Li; Zhiwu Jiang; Qiting Wu; Youguo Long; Suna Wang; Zhaoyang Tang; Huixia Pan; Xiaoping Li; Wei Wei; Jie Yang; Xuequn Luo; Zhenfeng Zhang; Qiannan Tang; Pentao Liu; Robert Weinkove; Yao Yao; Dajiang Qin; Jean Paul Thiery; Peng Li
Journal:  Nat Commun       Date:  2022-10-13       Impact factor: 17.694

5.  The CD70-CD27 axis, a new brake in the T helper 17 cell response.

Authors:  Xiaohu Wang; Chen Dong
Journal:  Immunity       Date:  2013-01-24       Impact factor: 31.745

6.  CD70 is downregulated by interaction with CD27.

Authors:  Mirela Kuka; Ivana Munitic; Maria Letizia Giardino Torchia; Jonathan D Ashwell
Journal:  J Immunol       Date:  2013-08-02       Impact factor: 5.422

Review 7.  TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy?

Authors:  Amit Kumar; Wasim Abbas; Georges Herbein
Journal:  Mediators Inflamm       Date:  2013-12-19       Impact factor: 4.711

8.  CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response.

Authors:  Katherine A Riccione; Li-Zhen He; Peter E Fecci; Pamela K Norberg; Carter M Suryadevara; Adam Swartz; Patrick Healy; Elizabeth Reap; Tibor Keler; Qi-Jing Li; Kendra L Congdon; Luis Sanchez-Perez; John H Sampson
Journal:  Oncoimmunology       Date:  2018-09-05       Impact factor: 8.110

9.  In vitro HIV-1 LTR integration into T-cell activation gene CD27 segment and the decoy effect of modified-sequence DNA.

Authors:  Rei Ohmori; Tatsuaki Tsuruyama
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.